Wolverine Trading
UTHR icon

Wolverine Trading’s United Therapeutics UTHR Stock Holding History

Wolverine Trading’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-1,307
Closed -$440K – 6230
2025
Q2 		$372K Buy
+1,307
New +$391K ﹤0.01% 3242
2022
Q4 		– Sell
-1,074
Closed -$223K – 5096
2022
Q3 		$223K Buy
+1,074
New +$240K ﹤0.01% 3485
2021
Q4 		– Sell
-2,410
Closed -$473K – 6901
2021
Q3 		$447K Sell
2,410
-2,009
-45% -$396K ﹤0.01% 4107
2021
Q2 		$782K Buy
4,419
+1,877
+74% +$357K ﹤0.01% 3100
2021
Q1 		$421K Sell
2,542
-358
-12% -$59.7K ﹤0.01% 3971
2020
Q4 		$431K Buy
+2,900
New +$381K ﹤0.01% 3337
2019
Q4 		– Sell
-2,473
Closed -$200K – 5247
2019
Q3 		$200K Buy
+2,473
New +$199K ﹤0.01% 3590
2018
Q3 		– Sell
-10,618
Closed -$1.31M – 5931
2018
Q2 		$1.19M Hold
10,618
– – ﹤0.01% 2072
2018
Q1 		$1.19M Sell
10,618
-7,286
-41% -$926K ﹤0.01% 2072
2017
Q4 		$2.65M Buy
17,904
+16,152
+922% +$2.05M 0.01% 1314
2017
Q3 		$205K Sell
1,752
-14,357
-89% -$1.83M ﹤0.01% 3778
2017
Q2 		$2.12M Buy
16,109
+14,248
+766% +$1.78M 0.01% 1206
2017
Q1 		$254K Sell
1,861
-2,890
-61% -$438K ﹤0.01% 3225
2016
Q4 		$681K Buy
+4,751
New +$607K ﹤0.01% 2289

Other funds holding UTHR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Wolverine Trading's UTHR Position: Q3 2025 in Review

Wolverine Trading sold out of United Therapeutics (UTHR) in Q3 2025, closing a stake of 1,307 shares — an estimated $440K sold.

Wolverine Trading first reported a position in UTHR in Q4 2016 and held it in 14 quarters. The position peaked at $2.65M in Q4 2017. 707 funds tracked by Wall St. Rank hold UTHR as of Q3 2025.

  • Wolverine Trading reported no remaining United Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Wolverine Trading sold 1,307 United Therapeutics shares in Q3 2025, an estimated $440K.
  • Wolverine Trading first reported a position in United Therapeutics in Q4 2016 and held it in 14 quarters.
  • Wolverine Trading's United Therapeutics position peaked at $2.65M in Q4 2017.
  • 707 funds tracked by Wall St. Rank held United Therapeutics as of Q3 2025.

Based on Wolverine Trading's 13F filing for Q3 2025, filed 14 Nov 2025.